SecBot SecBot

AARD

Aardvark Therapeutics, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001774857 Biotech & Drug Discovery
$1.39 −2.56 (−64.81%)
Oct 23 4:00 PM ET · prev $3.95
Market cap
$86.4M
Micro cap
Consensus
Buy
61% Buy or better · 18 analysts
Median target
🔒 Subscribers only
1 year
−87.0%
from $10.70 · Oct 24
30 days
−75.0%
from $5.55
52-week range
$1.39–15.82
at the low
Avg volume 20D
994.1K
Oct 23 spike 16.14M
Short interest
474.1K
≈2.2% of shares · +11.6%
Days to cover
5.3
at average volume
Insider net
-$395.0K
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 1 mention this week
SecBot read MIXED 8 reports · 90 days
Balance 3 bearish · 2 bullish · 1 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 7/8 ·Next Earnings date, Nov 12, 2026
Strongest BULLISH Aardvark Therapeutics announced that the FDA has lifted the clinical hold on its IND for ARD-101 for…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $395.0K.

  • InstitutionsMIXED

    Q2 2026: 10 added (0 new), 13 trimmed or exited.

  • AnalystsBULLISH

    11 of 18 rate it Buy or better.

  • Short sellersSTEADY

    Short interest +11.6% to 474.1K shares. 5.3 days to cover, ≈2.2% of shares.

  • TrendDOWNTREND

    74% below its 50-day average. New closing low $1.39 on Oct 23.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup call.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.NEAR_EXIT187,045$1.1M
GEODE CAPITAL MANAGEMENT, LLCTRIM149,844$863.5K
RAYMOND JAMES FINANCIAL INCDOUBLED79,284$456.7K
MILLENNIUM MANAGEMENT LLCTRIM69,948$402.9K
STATE STREET CORPTRIM59,273$341.4K
IEQ CAPITAL, LLCDOUBLED38,382$221.1K
UBS Group AGNEAR_EXIT35,639$205.3K
MORGAN STANLEYADD30,177$173.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

18 analysts
Buy 61% rate it Buy or better
Strong Buy5Buy6Hold5Sell2Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 26, 2026🔒 Fresh data — subscribers only
MAINTAIN
MAINTAIN
Oct 19, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINNeutral
Sep 24, 2026RBC Capital
REITERATE
REITERATESector Perform
Jul 20, 2026HC Wainwright & Co.
REITERATE
REITERATENeutral
May 15, 2026B. Riley Securities
MAINTAIN
MAINTAINBuy
May 15, 2026BTIG
DOWNGRADE
DOWNGRADENeutral

Insider ledger

Form 4
$0
bought · 0 insiders
$395.0K
sold · 1 insider
DateInsiderTypeValue
Oct 7, 2026
Zhang Zhongwei
Director
AWARD127,061 sh
Sep 11, 2026
Sun Nelson
See Remarks
SELL$321.2K
Sep 10, 2026
Sun Nelson
See Remarks
SELL$73.8K
Aug 14, 2026
Tong Victor Edward Jr
Director
AWARD44,964 sh
Aug 14, 2026
Chi Jeffrey
Director
AWARD44,964 sh
Aug 14, 2026
Baynes Roy D.
Director
AWARD44,964 sh
Aug 14, 2026
Graf Susan E
Director
AWARD44,964 sh
Feb 9, 2026
Lee Tien-Li
Chief Executive Officer
AWARD203,851 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 1 in posts · 0 in comments
Recent posts
r/pennystocks Neutral 3d ago
23 OCT 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
1 upvotes · 1 comments
All social signals and their track records

Short side

FINRA· Sep 30, 2026
474,080
shares short
+11.6%
vs prior settlement
5.3
days to cover
≈2.2%
of shares outstanding
Trading halts
Oct 23, 2026Volatility PauseResumed
Oct 23, 2026Volatility PauseResumed
Oct 23, 2026Volatility PauseResumed
Oct 22, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 23, 2026 SEC
Aardvark Therapeutics reported exploratory efficacy data from its terminated Phase 3 HERO trial and open-label…
8-K — Impact 6/10
Oct 23, 2026 Trading halt
Halt Resumed: AARD — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-23T13:51:55.000Z | Resumed 2026-10-23T13:56:55.000Z
Oct 22, 2026 SEC
Aardvark Therapeutics announced that the FDA has lifted the clinical hold on its IND for ARD-101 for hyperphagia in…
8-K — Impact 7/10
Oct 22, 2026 Press
FDA lifted the clinical hold on Aardvark's IND for ARD-101 in Prader-Willi Syndrome, allowing clinical development to…
Impact 7/10
Oct 8, 2026 SEC
Zhongwei Zhang filed an initial statement of beneficial ownership (Form 3) with the SEC, disclosing his position as a…
3 — Impact 1/10
Oct 7, 2026 Insider
Zhang Zhongwei was granted 127,061 shares
Director
Sep 11, 2026 Insider
Sun Nelson sold 62,000 shares
See Remarks @ $5.18 ($321.2K)
Sep 10, 2026 Insider
Sun Nelson sold 14,754 shares
See Remarks @ $5.00 ($73.8K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
🔒 Fresh data — subscribers only
Recent
Oct 23, 2026
Trading halt
Halt Resumed: AARD — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-23T13:51:55.000Z | Resumed 2026-10-23T13:56:55.000Z
Oct 23, 2026
Trading halt
Trading Halt: AARD — LUDP (Volatility Trading Pause)
Aardvark Therapeutics, Inc. CS | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 23, 2026
Trading halt
Halt Resumed: AARD — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-23T13:45:33.000Z | Resumed 2026-10-23T13:50:33.000Z
Oct 23, 2026
Trading halt
Trading Halt: AARD — LUDP (Volatility Trading Pause)
Aardvark Therapeutics, Inc. CS | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 23, 2026
Trading halt
Halt Resumed: AARD — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-23T13:39:20.000Z | Resumed 2026-10-23T13:44:20.000Z

SecBot reports

13 filings · 3 press releases · 1 bullish · 7 bearish · 1 mixed · 4 neutral
All AARD filing & press-release reports (16)